Showing results (371-380 of 495) with videos related to
Sort By:
Pageof 50
Eye (London, England)|February 18, 2017
Aflibercept as a Second Line Therapy for Neovascular Age Related Macular Degeneration in Israel (ASLI) studyL Tiosano, O Segal, N Mathalone, et al.Israel Journal of Medical Sciences|March 1, 1986
New approaches for the prevention of rejection and graft-vs.-host disease in clinical bone marrow transplantationS Slavin, R Or, E Naparstek, et al.Urology|December 1, 1994
Significance of tumor angiogenesis in clinically localized prostate carcinoma treated with external beam radiotherapyM C Hall, P Troncoso, A Pollack, et al.Cancer Causes & Control : CCC|October 7, 2005
Cancer survivorship: a new challenge in comprehensive cancer controlLori A Pollack, Greta E Greer, Julia H Rowland, et al.Journal of Biomedical Informatics|June 22, 2016
Think twice: A cognitive perspective of an antibiotic timeout intervention to improve antibiotic useMakoto Jones, Jorie Butler, Christopher J Graber, et al.Journal of Substance Abuse Treatment|June 17, 2019
Medicaid coverage in substance use disorder treatment after the affordable care actChristina M Andrews, Harold A Pollack, Amanda J Abraham, et al.The Prostate|April 1, 1997
The significance of DNA-ploidy and S-phase fraction in node-positive (stage D1) prostate cancer treated with androgen ablationA Pollack, P Troncoso, G K Zagars, et al.SSM. Mental Health|July 22, 2024
Racial discrimination and mental health in the context of anti-Asian xenophobia: An intersecting approach of race, ethnicity, nativity, and socioeconomic statusYen-Tyng Chen, Yuqing Zhou, Sharifa Williams, et al.Oncology Nursing Forum|October 29, 2013
Barriers and facilitators to implementing cancer survivorship care plansDorothy Dulko, Claire M Pace, Kim L Dittus, et al.Journal of the National Cancer Institute|May 1, 1983
In vivo selection of androgen-insensitive cells in R3327-G rat prostate tumors: diethylstilbestrol diphosphate treatment versus orchiectomyA Pollack, N L Block, B J Stover, et al.Pageof 50